Hospitals and health systems - Insights
Mayo Clinic Laboratories can help hospital laboratories leverage the power of their labs through advanced, high-quality testing, customized consultative services, and tailored business solutions.
New Eligibility Guidelines for Blood Donors with Previous Cancer Diagnoses - Insights
To coincide with American Red Cross recommendations, the Mayo Clinic Blood Donor Program has redefined eligibility guidelines for donors who have had a history of previous cancer diagnoses.
On the April 22 broadcast of Mayo Clinic Radio, co-hosts Tracy McCray and Tom Shives, M.D., spoke with Bobbi Pritt, M.D., Director of the Clinical Parasitology Laboratory, about an update on Lyme disease predictions for 2017.
Find out how our BioPharma Diagnostics capabilities can support your precision medicine initiatives, from discovery to post market.
Serotonin release assay - Insights
Find out more about our serotonin release assay, the gold standard diagnostic test for detecting heparin-induced thrombocytopenia antibodies.
Lysosomal Storage Disease Panel by NGS [Test in Focus] - Insights
Devin Oglesbee, Ph.D., Director of the Biochemical and Molecular Genetics Laboratories at Mayo Clinic, provides an overview of the lysosomal storage disease panel, when it is appropriate to order this test, what actions the results allow...
While the diagnostic criteria of celiac disease are well defined, symptoms are generally nonspecific. This fact, combined with the variety of available tests — each with a specific utility and interpretation — can make a diagnosis...
mast_cell_disorder_diagnostic_algorithm__bone_marrow.pdf
01/2025© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Mast Cell Disorder: Diagnostic Algorithm, Bone Marrow NORMAL ABNORMAL Mast cells observed Other hematologic cells observed Order initial testing: ■...
search - Mayo Clinic Laboratories
Search Results Test Catalog...
Alzheimer's Disease CSF Biomarkers - Insights
In this month's "Hot Topic," Alicia Algeciras, Ph.D., DABCC, and Joshua Bornhorst, Ph.D., DABCC, discuss Alzheimer's disease CSF biomarkers.